Skip to main content

NeuroPace Inc

NPCE
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001528287

In the last 90 days, NeuroPace Inc insiders filed 3 open-market purchases and 0 sales; 104 institutions reported holding it in 13F filings for Q3 2026, worth $369.0M in total; no superinvestor holds it.

Holders of 5% or more of NPCE

Holders whose latest Schedule 13D or 13G filing reports 5% or more of NeuroPace Inc, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of NPCE
HolderLatest formStakeChangeFirst filedLatest filingFiling
First Light Asset Management, LLC13G/A12.25%4.20M shares+3.58 ppfrom 8.67%May 15, 20262 filingsSep 4, 2026SEC
Polar Capital Holdings Plc13G9.13%2.97M sharesNewMay 15, 20251 filingMay 15, 2025SEC
Soleus Private Equity Fund I, L.P.13G/A8.90%2.96M shares–Nov 1, 20216 filingsNov 7, 2025SEC
Morgan Stanley13G/A8.30%2.49M shares–Feb 10, 20233 filingsFeb 4, 2025SEC
Soleus Capital Master Fund, L.P.13G/A7.00%2.30M shares–Aug 5, 20251 filingAug 5, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

35 Schedule 13D and 13G filings on NeuroPace Inc, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on NPCE
Filed (ET)FilerFormStakeChangeEvent dateFiling
Sep 4, 20264:45 PM ETFirst Light Asset Management, LLCand 1 other13G/A12.25%4.20M shares+3.58 ppfrom 8.67%Aug 31, 2026SEC
Aug 14, 20265:40 PM ETOrbiMed Advisors LLCand 1 other13G/A4.40%1.51M shares−1.80 ppfrom 6.20%Below 5%Jun 30, 2026SEC
May 15, 20264:41 PM ETFirst Light Asset Management, LLCand 1 other13G8.67%2.96M sharesNewMar 31, 2026SEC
May 15, 20264:35 PM ETOrbiMed Advisors LLCand 1 other13G/A6.20%2.10M shares−1.80 ppfrom 8.00%Mar 31, 2026SEC
Nov 7, 20254:00 PM ETSoleus Private Equity Fund I, L.P.and 8 others13G/A8.90%2.96M shares–Sep 30, 2025SEC
Sep 3, 20254:48 PM ETKCK Ltd.13G/A0.00%0 shares−17.70 ppfrom 17.70%Below 5%Feb 20, 2025SEC
Aug 14, 20256:03 PM ETOrbiMed Advisors LLCand 1 other13G/A8.00%2.61M shares−2.50 ppfrom 10.50%Jun 30, 2025SEC
Aug 5, 20255:00 PM ETSoleus Capital Master Fund, L.P.and 8 others13G/A7.00%2.30M shares–Jun 30, 2025SEC
May 15, 20258:15 PM ETOrbiMed Advisors LLCand 1 other13G/A10.50%3.41M shares–Mar 31, 2025SEC
May 15, 202510:21 AM ETPolar Capital Holdings Plcand 1 other13G9.13%2.97M sharesNewMar 31, 2025SEC
Feb 14, 20252:07 PM ETKent Lake PR LLCand 2 others13G/A4.90%1.48M shares−0.10 ppfrom 5.00%Below 5%Dec 31, 2024SEC
Feb 11, 20254:38 PM ETKCK Ltd.13G/A17.70%5.27M shares–Dec 31, 2024SEC
Feb 4, 202512:50 PM ETMorgan Stanleyand 1 other13G/A8.30%2.49M shares–Dec 31, 2024SEC
Nov 14, 2024Soleus Private Equity Fund I, L.P.13G/AOld format–––SEC
Nov 14, 2024OrbiMed Advisors LLC13G/AOld format–––SEC
Nov 4, 20244:51 PM ETKent Lake PR LLCand 2 others13G5.00%1.47M sharesNewOct 25, 2024SEC
Oct 3, 2024KCK Ltd.13G/AOld format–––SEC
Feb 14, 2024KCK Ltd.13G/AOld format–––SEC
Feb 14, 2024OrbiMed Advisors LLC13G/AOld format–––SEC
Feb 9, 2024Morgan Stanley13G/AOld format–––SEC
Feb 9, 2024FMR LLC13G/AOld format–––SEC
Feb 2, 2024Soleus Private Equity Fund I, L.P.13G/AOld format–––SEC
Feb 14, 2023Soleus Private Equity Fund I, L.P.13G/AOld format–––SEC
Feb 14, 2023OrbiMed Advisors LLC13G/AOld format–––SEC
Feb 10, 2023Morgan Stanley13GOld format–New–SEC
Feb 9, 2023FMR LLC13GOld format–New–SEC
Nov 23, 2022Accelmed Partners II L.P.13D/AOld format–––SEC
Nov 21, 2022Accelmed Partners II L.P.13DOld format–New–SEC
Oct 7, 2022KCK Ltd.13GOld format–New–SEC
Feb 11, 2022OrbiMed Advisors LLC13G/AOld format–––SEC
Feb 10, 2022Soleus Private Equity Fund I, L.P.13G/AOld format–––SEC
Jan 13, 20224:23 PM ETMedtronic plc13GOld format–––SEC
Nov 1, 2021Soleus Private Equity Fund I, L.P.13GOld format–New–SEC
May 3, 20219:32 AM ETMedtronic plc13GOld format–New–SEC
Apr 29, 2021OrbiMed Advisors LLC13GOld format–New–SEC

Form 144: proposed insider sales

11 notices from officers, directors and other affiliates planning to sell NeuroPace Inc shares, newest first.

Form 144 notices for NPCE
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Dec 15, 20254:26 PM ETMartha J MorrellOfficer25.0K$404.8KDec 15, 202510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jan 30, 20254:11 PM ETMartha J MorrellOfficer78.5K$1.15MJan 30, 202510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jan 29, 20254:26 PM ETMartha J MorrellOfficer100$1.41KJan 29, 202510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jan 24, 20254:30 PM ETMartha J MorrellOfficer3.20K$44.9KJan 24, 202510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Oct 28, 20247:02 AM ETKCK Ltd.10% stockholder224.0K$1.22MOct 25, 2024Goldman Sachs & Co. LLCSEC
Oct 3, 20244:05 PM ETKCK Ltd.10% stockholder190.0K$1.47MAug 30, 2024Goldman Sachs & Co. LLCSEC
Mar 15, 20245:07 PM ETIrina RidleyChief Legal Officer3.94K$53.6KMar 15, 202410b5-1J.P. Morgan Securities LLCSEC
Dec 20, 20235:18 PM ETMartha MorrellChief Medical Officer48.4K$483.5KDec 20, 202310b5-1J.P. Morgan Securities LLCSEC
Dec 6, 20235:59 PM ETMartha MorrellAffiliate11.0K$89.8KDec 6, 202310b5-1J.P. Morgan Securities LLCSEC
Nov 29, 20231:37 PM ETKCK Ltd.Shareholder262.8K$2.30MNov 27, 2023Goldman Sachs & Co. LLCSEC
Oct 2, 20238:46 PM ETOrbiMed Private Investments VI, LPShareholder288.1K$2.56MOct 2, 2023JP Morgan Chase & Co.SEC